
Bär & Karrer Ltd. leverages its capabilities across the full range of healthcare and life sciences matters, including IP, licensing, R&D, M&A, patent litigation, investigations and related regulatory issues. Markus Schott routinely represents clients from across the industry in contentious administrative proceedings and also oversees governmental supervision and public procurement matters. Markus Wang heads the firm’s IP offering and provides advice on contentious and non-contentious patent issues. Dispute resolution expert Oliver M. Brupbacher acts in litigation, investigations and arbitration, as well compliance counselling and risk management mandates, often with a cross-border element. The three jointly lead the team. Djamila Batache is a name to note for questions of product liability and regulatory matters.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- ‘Outstanding work from Oliver M. Brupbacher. He's super available and knowledgeable on Swiss regulations, very responsive and a pleasure to work with.’
- ‘The team is clearly the spearhead of the Swiss law firms specialising in healthcare and life sciences.’
- ‘They have real in-house experience, combined with excellent technical skills, which makes everything way easier!’
- ‘Oliver M. Brupbacher has been an amazing partner to work with. He helped us with his strategic thinking and added value to sophisticated legal challenges.’
- 'The Bär & Karrer team supported us on a complex cross-border, security-backed financing transaction and delivered outstanding work throughout.'
- 'Their depth of expertise, professionalism and commitment to high-quality execution make them a trusted partner for sophisticated, cross-border corporate and financing matters.’
Key clients
- Novartis
- Pro Medicus
- Moderna
- HAS Healthcare Advanced Synthesis SA
Work highlights
Provided strategic and legal advice to the group litigation, investigations, M&A, tax and commercial teams at Novartis.
Advised Pro Medicus AG in connection with its contractual arrangements and the implementation of the procura program.
Advised Moderna on various legal matters in connection with its business in Switzerland and abroad.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Markus Schott; Oliver M. Brupbacher; Markus Wang
Other key lawyers
Djamila Batache
Comparative Guides
Comparative Guide
Venture Capital
Switzerland
Raphael Annasohn, Philippe Seiler, Susanne Schreiber, Martin Leu & Julian Lindt
Comparative Guide
Private Equity
Switzerland
Dr. Christoph Neeracher, Philippe Seiler & Raphael Annasohn
Comparative Guide
Blockchain & Crypto Assets
Switzerland
Daniel Flühmann & Peter Ch. Hsu
Comparative Guide
Sports Law
Switzerland
Michele Bernasconi, Emanuel Cortada & Jonáš Gürtler


